Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.

PubWeight™: 1.87‹?› | Rank: Top 3%

🔗 View Article (PMID 18664956)

Published in AIDS on July 01, 2008


Sergio Bautista-Arredondo1, Paola Gadsden, Jeffrey E Harris, Stefano M Bertozzi

Author Affiliations

1: National Institute of Public Health, Cuernavaca, Mexico.

Articles citing this

Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56

Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography. PLoS One (2016) 1.62

Knowing your HIV/AIDS epidemic and tailoring an effective response: how did India do it? Sex Transm Infect (2012) 1.40

The past, present and future of HIV, AIDS and resource allocation. BMC Public Health (2009) 1.24

How much can we gain from improved efficiency? An examination of performance of national HIV/AIDS programs and its determinants in low- and middle-income countries. BMC Health Serv Res (2012) 1.16

Decision making for HIV prevention and treatment scale up: bridging the gap between theory and practice. Med Decis Making (2010) 1.04

Developing and evaluating comprehensive HIV infection control strategies: issues and challenges. Clin Infect Dis (2010) 1.02

Cost-effectiveness of an intervention to reduce HIV/STI incidence and promote condom use among female sex workers in the Mexico-US border region. PLoS One (2010) 0.95

Indices to measure risk of HIV acquisition in Rakai, Uganda. PLoS One (2014) 0.94

Recommendations for increasing the use of HIV/AIDS resource allocation models. BMC Public Health (2009) 0.88

Assessing cost and technical efficiency of HIV prevention interventions in sub-Saharan Africa: the ORPHEA study design and methods. BMC Health Serv Res (2014) 0.83

Prevention of Parent to Child Transmission (PPTCT) program data in India: an emerging data set for appraising the HIV epidemic. PLoS One (2012) 0.78

Empirical evidence of the continuing improvement in cost efficiency of an endoscopic surveillance programme for gastric cancer in Singapore from 2004 to 2010. BMC Health Serv Res (2013) 0.76

Value for Money in Donor HIV Funding. Rand Health Q (2012) 0.75

Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics. PLoS One (2017) 0.75

The welfare costs of HIV/AIDS in eastern Europe: an empirical assessment using the economic value-of-life approach. Eur J Health Econ (2009) 0.75

Articles by these authors

Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med (2009) 8.99

HIV prevention transformed: the new prevention research agenda. Lancet (2011) 4.23

High risk of HIV in non-brothel based female sex workers in India. BMC Public Health (2005) 3.58

Sex behaviour of men who have sex with men and risk of HIV in Andhra Pradesh, India. AIDS (2005) 3.35

Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost? Lancet (2004) 3.14

Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico. J Urban Health (2006) 3.04

Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico. AIDS (2006) 2.87

HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res (2007) 2.55

Current priorities in health research funding and lack of impact on the number of child deaths per year. Am J Public Health (2006) 2.44

Combination HIV prevention. Lancet (2008) 2.10

Tobacco control campaign in Uruguay: a population-based trend analysis. Lancet (2012) 2.01

Demography and sex work characteristics of female sex workers in India. BMC Int Health Hum Rights (2006) 1.76

HIV prevention cost-effectiveness: a systematic review. BMC Public Health (2009) 1.58

Heterogeneous impact of the "Seguro Popular" program on the utilization of obstetrical services in Mexico, 2001-2006: a multinomial probit model with a discrete endogenous variable. J Health Econ (2008) 1.50

How the Avahan HIV prevention program transitioned from the Gates Foundation to the government of India. Health Aff (Millwood) (2013) 1.50

Emergency contraception use is correlated with increased condom use among adolescents: results from Mexico. J Adolesc Health (2004) 1.33

Evaluation of large-scale combination HIV prevention programs: essential issues. J Acquir Immune Defic Syndr (2011) 1.32

Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study. PLoS One (2009) 1.24

The costs, benefits, and cost-effectiveness of interventions to reduce maternal morbidity and mortality in Mexico. PLoS One (2007) 1.18

Variations in prenatal care quality for the rural poor in Mexico. Health Aff (Millwood) (2007) 1.17

Community-based prevention leads to an increase in condom use and a reduction in sexually transmitted infections (STIs) among men who have sex with men (MSM) and female sex workers (FSW): the Frontiers Prevention Project (FPP) evaluation results. BMC Public Health (2010) 1.15

Risk behaviors of 15-21 year olds in Mexico lead to a high prevalence of sexually transmitted infections: results of a survey in disadvantaged urban areas. BMC Public Health (2006) 1.13

Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008. AIDS (2007) 1.09

HIV prevention in Mexican schools: prospective randomised evaluation of intervention. BMJ (2006) 1.09

Using provider performance incentives to increase HIV testing and counseling services in Rwanda. J Health Econ (2014) 1.03

Costing of scaling up HIV/AIDS treatment in Mexico. Salud Publica Mex (2008) 1.02

How much attention is needed towards men who sell sex to men for HIV prevention in India? BMC Public Health (2006) 1.02

HIV testing among female sex workers in Andhra Pradesh, India. AIDS (2005) 1.01

Correlates of condom use in a sample of MSM in Ecuador. BMC Public Health (2006) 0.99

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico. BMC Infect Dis (2008) 0.96

High prevalence of obesity among the poor in Mexico. JAMA (2004) 0.95

Willingness-to-accept reductions in HIV risks: conditional economic incentives in Mexico. Eur J Health Econ (2013) 0.95

Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks. Am J Trop Med Hyg (2008) 0.91

Evaluation of HIV prevention programmes: the case of Avahan. Sex Transm Infect (2010) 0.89

Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting. Health Policy Plan (2003) 0.88

Cash and in-kind transfers lead to excess weight gain in a population of women with a high prevalence of overweight in rural Mexico. J Nutr (2013) 0.88

Optimizing HIV treatment programs. Curr Opin HIV AIDS (2010) 0.87

Access to condoms for female sex workers in Andhra Pradesh. Natl Med J India (2007) 0.86

Cost of AIDS care in Mexico: what are its main individual predictors? Arch Med Res (2005) 0.84

A Cross-Sectional Study of Prisoners in Mexico City Comparing Prevalence of Transmissible Infections and Chronic Diseases with That in the General Population. PLoS One (2015) 0.83

Can cost studies improve the performance of donor-financed HIV treatment? AIDS (2011) 0.81

Herpes simplex virus type 2 among Mexican high school adolescents: prevalence and association with community characteristics. Arch Med Res (2007) 0.80

[A novel school-based strategy for the prevention of HIV/AIDS, sexually transmitted disease (STDs), and teen pregnancies]. Salud Publica Mex (2006) 0.80

Finite element analysis of lordosis restoration with anterior longitudinal ligament release and lateral hyperlordotic cage placement. Eur Spine J (2015) 0.80

The economic impacts of HIV/AIDS on households and economies. AIDS (2008) 0.79

Improving enrollment and utilization of the Oportunidades program in Mexico could increase its effectiveness. J Nutr (2008) 0.79

Cash and in-kind transfers in poor rural communities in Mexico increase household fruit, vegetable, and micronutrient consumption but also lead to excess energy consumption. J Nutr (2010) 0.79

[Facing the HIV/AIDS epidemic in Mexico: the response of the health sector]. Rev Invest Clin (2004) 0.79

Stakeholders' opinions and expectations of the Global Fund and their potential economic implications. AIDS (2008) 0.78

A predictive model for the utilization of curative ambulatory health services in Mexico. Salud Publica Mex (2008) 0.78

[Influenza vaccination in the elderly population in Mexico: economic considerations]. Salud Publica Mex (2005) 0.76

Publishing nutrition research: a review of multivariate techniques--part 3: data reduction methods. J Acad Nutr Diet (2015) 0.76

Scaling up HAART in Mexico. Response to Volkow et al. AIDS (2007) 0.75

Improving access to treatment for HIV in sub-Saharan Africa. BMJ (2010) 0.75

Post-emergency: providing effective, sustainable, life-long care to everyone with AIDS. Indian J Med Res (2006) 0.75

[Mixed design for the evaluation of the Mesoamerica Health 2015 initiative]. Salud Publica Mex (2011) 0.75

Mixed-Methods Research in Nutrition and Dietetics. J Acad Nutr Diet (2017) 0.75

[Cost-effectiveness of breast cancer screening policies in Mexico]. Salud Publica Mex (2009) 0.75

The Challenge of Connecting Dietary Changes to Improved Disease Outcomes: The Balance between Positive, Neutral, and Negative Publication Results. J Acad Nutr Diet (2016) 0.75

Informing scale-up and resource allocation: the use of economic analysis. AIDS (2008) 0.75

Combining evidence for access to and benefits from antiretroviral treatment to inform planning. AIDS (2008) 0.75

[The health gap in Mexico, measured through child mortality]. Salud Publica Mex (2003) 0.75

Crossover Designs in Nutrition and Dietetics Research. J Acad Nutr Diet (2017) 0.75

Re: This special issue of AIDS--a mix of recent economic analyses and commentary on how best to distill economic insights to improve HIV/AIDS policies and programmes. AIDS (2008) 0.75